ArticleActa biomaterialia2021

Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer.

Wu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.